跳轉至內容
Merck
全部照片(1)

重要文件

查看所有文件

T-047

Supelco

(±)-Δ9-四氢大麻酚标准液 溶液

100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C21H30O2
CAS號碼:
6465-30-1
分子量：:
314.46
EC號碼:
205-563-8
分類程式碼代碼:
41116107
NACRES:
NA.24

品質等級

300

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

濃度

100 μg/mL in heptane

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

cannabis testing
cannabis testing

形式

single component solution

儲存溫度

−20°C

SMILES 字串

O1C(C2C(c3c1cc(cc3O)CCCCC)C=C(CC2)C)(C)C

InChI

1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3

InChI 密鑰

CYQFCXCEBYINGO-UHFFFAOYSA-N

相關類別

一般說明

(±)-Δ9-THC是大麻的主要活性成分和主要精神活性大麻素。除持续非法使用外，该药还适合治疗厌食症和恶心，以商品名Marinol®出售。该Certified Spiking Solution®适合用作从法医分析和临床毒理学研究到尿液药物检测的各种LC/MS或GC/MS应用的校准品或对照品的起始材料。

應用


  • 聚合物纳米颗粒粒的药物释放：本研究重点介绍了乙酸乙酯在调节聚乳酸-羟基乙酸共聚物纳米颗粒的药物释放行为中的作用，说明了其在药物制剂中的适用性（Wang et al., 2024）。

  • 生物碱的制备性分离：研究人员开发了一种使用乙酸乙酯、增强高速逆流色谱和制备型高效液相色谱技术来分离和纯化钩吻中生物碱的方法（Liang et al., 2024）

  • 抗菌菌株表征：研究人员将乙酸乙酯用于枯草芽孢杆菌菌株O-741的分离和鉴定，证明了其对副溶血弧菌的有效性和广泛的生物医学应用潜力（Chen et al., 2024）。


其他說明

仅供定量使用

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Marinol is a registered trademark of Unimed Pharmaceuticals, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

產品號碼
描述
訂價

C-115

Cannabinol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-026

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-027

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-041

(±)-11-Hydroxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

−-Δ9-四氢大麻酚-D3标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-004

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-006

(±)-Δ-四氢大麻酸标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-007

(±)-11-nor-9-Carboxy-Δ9-THC-D9 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-008

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-011

−-Δ9-四氢大麻酚-D3标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-018

(−)-11-nor-9-羧基-Δ9-THC 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-019

(−)-11-nor-9-羧基-Δ9-THC 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-038

(+)-11-去甲-Δ9-THC-9-羧酸葡糖苷酸 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-080

(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-159

(6aR, 9S)-delta10-THC solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

T-171

(6aR, 9R)-delta10-THC solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

H-166

11-Nor-9beta-hydroxyhexahydrocannabinol (11-Nor-9beta-HHC) solution, 1 mg/mL (Acetonitrile (Degas)), certified reference material, ampule of 1 mL, Cerilliant®

T-158

(-)-11-nor-9-Carboxy-Delta8-THC-D3 solution, 100 μg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

H-165

Hexahydrocannabinol (HHC) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

訊號詞

Danger

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

24.8 °F - closed cup

閃點（°C）

-4 °C - closed cup

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

抱歉，我們目前沒有在線上提供本產品的COA

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Suspected dronabinol withdrawal in an elderly cannabis-naive medically ill patient.
Russ S Muramatsu et al.
The American journal of psychiatry, 170(7), 804-804 (2013-07-04)
M Waldman et al.
Biochemical pharmacology, 85(11), 1626-1633 (2013-03-30)
Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family. Both CB1 and
David R Maguire et al.
The Journal of pharmacology and experimental therapeutics, 345(3), 354-362 (2013-03-29)
Cannabinoid receptor agonists enhance the antinociceptive effects of μ-opioid receptor agonists, which suggests that combinations of these drugs might enhance therapeutic effectiveness (e.g., analgesia). However, it is not clear whether combinations of these drugs also enhance abuse or dependence liability.
Going to pot.
Roxanne Khamsi
Scientific American, 308(6), 34-34 (2013-06-05)
J M Jansma et al.
Translational psychiatry, 3, e234-e234 (2013-02-28)
Recent evidence has implicated the endocannabinoid (eCB) system in nicotine addiction. The eCB system also has an important role in reward mechanisms, and nicotine addiction has been associated with aberrant reward processing. Motivated by this evidence, we tested the hypothesis
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務